Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002417610 | SCV002727089 | pathogenic | Hereditary cancer-predisposing syndrome | 2020-09-29 | criteria provided, single submitter | clinical testing | The p.E71* pathogenic mutation (also known as c.211G>T), located in coding exon 3 of the ATM gene, results from a G to T substitution at nucleotide position 211. This changes the amino acid from a glutamic acid to a stop codon within coding exon 3. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Laboratory for Genotyping Development, |
RCV003164550 | SCV002758074 | pathogenic | Gastric cancer | 2021-07-01 | no assertion criteria provided | research |